Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II PLX-PAD for moderate to severe chronic graft-versus-host disease after allogeneic transplant
MOH_2018-12-30_004869Phase 2Recruiting
- Sponsor
- ד"ר רון רם
- Start
- Jan 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of PLX-PAD in chronic graft-versus-host disease (cGVHD) (2 arms), sponsored by ד"ר רון רם. Primary endpoint: Safety. Started Jan 2018; status: recruiting.
02
Drugs
PLX-PAD
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on MOH_2018-12-30_004869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-12-30_004869.